
Next week, there will be votes on the legalization of recreational marijuana in Arkansas, Maryland, Missouri, North Dakota, and South Dakota.
If approved, these states would join 19 others (along with Washington D.C.) where recreational use is currently legal. According to the National Conference of State Legislatures, 37 states, three territories, and the District of Columbia allow for the medical use of cannabis products.
Currently, the medical marijuana being used for recreational purposes will be voted on and put to a decision on Tuesday in each of the five states where it is legal.
According to federal law, marijuana is illegal, even though some individual states have legalized it for recreational and medical purposes.
In October, the Biden administration announced that President Joe Biden had granted clemency to all individuals convicted of possessing federal marijuana through executive action.
Earlier this year, the leaders of the United States Senate proposed comprehensive legislation that would end the federal ban on marijuana, more than 50 years after it was classified as an illegal drug by Congress.
Statement:
This article has been compiled from third-party sources and is intended for industry communication and learning purposes only.
This article does not represent the views of 2FIRSTS, and 2FIRSTS is unable to confirm the authenticity and accuracy of the article's content. The translation of this article is intended for industry-related communication and research purposes only.
Due to limitations in our translation abilities, the translated article may not accurately reflect the original text. Please refer to the original article for accuracy and clarity.
2FIRSTS maintains complete alignment with the Chinese government concerning any domestic, Hong Kong-Macau-Taiwan related, or foreign statements and positions.
Information compilation belongs to the original media and authors. If there is any copyright infringement, please contact us for removal.
This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.